Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Mpa2 Inhibitors

Mpa2 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Mpa2, a protein involved in cellular processes such as protein degradation, regulation of the proteasome system, and possibly stress responses. Mpa2 is part of the proteasome regulatory complex, which plays a critical role in maintaining protein homeostasis by ensuring the timely degradation of misfolded or damaged proteins. Mpa2, through its interaction with other proteasome components, helps in recognizing and processing ubiquitinated proteins that are destined for degradation. By inhibiting Mpa2, researchers can interfere with these degradation pathways, offering a valuable tool to study how Mpa2 influences protein turnover, cellular stress responses, and the maintenance of cellular health.

In research settings, Mpa2 inhibitors provide insights into the molecular mechanisms of protein quality control and the broader implications of disrupted proteasome function on cellular physiology. Inhibition of Mpa2 allows scientists to explore how impairing proteasomal degradation affects the accumulation of proteins within the cell, particularly focusing on how this impacts the regulation of cellular processes such as cell cycle progression, signaling pathways, and the response to oxidative stress. This inhibition allows researchers to study the downstream effects of proteasome disruption, including the potential buildup of damaged proteins, alterations in cellular signaling networks, and the triggering of stress responses such as autophagy. Additionally, Mpa2 inhibitors are useful in investigating the interactions between Mpa2 and other regulatory proteins within the proteasome system, shedding light on the complex networks that govern protein turnover and cellular homeostasis. Through these studies, Mpa2 inhibitors enhance our understanding of the critical role of proteasome regulation in maintaining the balance of protein synthesis and degradation, as well as its broader implications for cellular function and longevity.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D may inhibit GBP4 expression by interfering with RNA polymerase activity, leading to decreased transcription of GBP4 mRNA.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide is suggested to inhibit GBP4 expression by interfering with protein synthesis, potentially leading to reduced levels of GBP4.

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$166.00
$322.00
436
(1)

Puromycin may inhibit GBP4 expression by incorporating into the growing peptide chain during protein synthesis, leading to reduced GBP4 levels.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin could potentially inhibit GBP4 expression by interfering with protein synthesis, potentially leading to decreased levels of GBP4.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Cisplatin is suggested to inhibit GBP4 expression by inducing DNA damage and triggering cellular stress responses that may downregulate GBP4 transcription.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide may inhibit GBP4 expression by inducing DNA damage and activating stress response pathways, potentially leading to decreased GBP4 transcription.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

Camptothecin is suggested to inhibit GBP4 expression by inducing DNA damage and triggering cellular stress responses that may downregulate GBP4 transcription.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

Doxorubicin may inhibit GBP4 expression by inducing DNA damage and activating stress response pathways, potentially leading to decreased GBP4 transcription.

Ellipticine

519-23-3sc-200878
sc-200878A
10 mg
50 mg
$145.00
$569.00
4
(1)

Ellipticine could potentially inhibit GBP4 expression by inducing DNA damage and interfering with the function of key transcriptional regulators of GBP4.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Mitomycin C is suggested to inhibit GBP4 expression by inducing DNA damage and triggering cellular stress responses that may downregulate GBP4 transcription.